Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,090,883
-$77,448 QoQ
Shares Held
5,753
-2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#655
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DE BURLO GROUP INC holds $41,576,322 across 7 Drug Manufacturers - General names. AZN ranks #3 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,613 | $31,920,433 | |
| 2 | ABBV |
AbbVie Inc.
|
26,039 | $6,552,453 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
5,753 | $1,090,883 | |
| 4 | NVO |
Novo Nordisk A S
|
15,250 | $731,085 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,758 | $727,465 | |
| 6 | JNJ |
Johnson & Johnson
|
1,333 | $338,542 | |
| 7 | AMGN |
Amgen Inc
|
595 | $215,461 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,090,883 | 5,753 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,168,331 | 5,924 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||